fda approved semaglutide approves obesity drug that helped people cut weight 15% π The FDA has approved
Description
Glapp also handles the practical side of GLP-1 therapy
Early data suggests it provides both substantial weight loss and glucose control (HbA1c reductions)

Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications widely used for type 2 diabetes and obesity
Your clinician reviews your medical history, goals, and biomarkers to determine eligibility
